CPAP delivered outside critical care during the second wave of COVID-19: outcomes from a UK respiratory surge unit.
Rebecca NightingaleJoseph LewisKatelyn Rhiannon MonsellLewis JonesChristopher SmithShantanu KunduHelena BondHassan BurhanTom FletcherThomas BlanchardMichael BeadsworthPeter HampshireManish GautamStacy ToddGareth JonesStephen AstonPublished in: BMJ open respiratory research (2021)
With adequate planning and resource redistribution, CPAP may be delivered effectively outside of a traditional critical care setting for the treatment of respiratory failure due to COVID-19. Clinicians delivering CPAP to patients with COVID-19 pneumonitis should be alert to the dangers of pulmonary barotrauma. Among patients who are for escalation of care, the use of CPAP may avoid the need for IMV in some patients. Our data support the NHS England recommendation to consider CPAP as a ceiling of care.
Keyphrases
- obstructive sleep apnea
- positive airway pressure
- sleep apnea
- coronavirus disease
- palliative care
- sars cov
- respiratory failure
- healthcare
- end stage renal disease
- quality improvement
- newly diagnosed
- chronic kidney disease
- ejection fraction
- pulmonary hypertension
- randomized controlled trial
- prognostic factors
- extracorporeal membrane oxygenation
- patient safety
- cross sectional
- rheumatoid arthritis
- clinical trial
- machine learning
- open label
- respiratory syndrome coronavirus
- chronic pain
- artificial intelligence
- data analysis
- double blind